Latiglutenase as a treatment for celiac disease
Ended Project Grant Awarded Last action
- Award ID
- R33AT009637
- Recipient
-
Immunogenx, Inc. UEI DHJSMHJ9BJE5
- Awarding agency
-
National Center for Complementary and Integrative Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $874,356
Award facts
- Assistance listing
- 93.213 Research and Training in Complementary and Integrative Health
- Completion date
- Originally
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $259,102 | |
| Original award | $615,254 |
Quick answers
Who received award R33AT009637?
R33AT009637 was awarded to Immunogenx, Inc. by National Center for Complementary and Integrative Health (National Institutes of Health) on September 15, 2017.
How much is award R33AT009637 worth?
$874,356 has been obligated on R33AT009637.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award